Acadia Healthcare Company, Inc. (NASDAQ: ACHC)

Acadia Healthcare Company, Inc. is a leading provider of behavioral healthcare services in the United States, operating a network of facilities that deliver acute inpatient psychiatric care, specialty treatment for substance use and co-occurring disorders, comprehensive treatment centers focused on medication-assisted treatment, and residential treatment centers for individuals with moderate to high acuity behavioral health needs. The company serves patients requiring stabilization and ongoing support for mental illness, addiction, and related conditions through a continuum of care designed to address complex and high-acuity populations.

Acadia Healthcare Company, Inc. generates revenue by providing behavioral healthcare services across its facility network, receiving payments from state Medicaid programs, commercial insurers, the federal Medicare program, and individual patients. The company’s revenue is derived from acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, and residential treatment centers, with service delivery supported by clinical staff including psychiatrists, therapists, nurses, and counselors who deliver evaluation, detoxification, medication-assisted treatment, therapy, and recovery planning.

The company operates through the following segments: Acute inpatient psychiatric facilities, Specialty treatment facilities, Comprehensive treatment centers, and Residential treatment centers.

• Acute inpatient psychiatric facilities provide 24-hour observation, daily intervention, and monitoring by psychiatrists to stabilize patients who are a threat to themselves or others, offering evaluation and crisis stabilization for severe psychiatric diagnoses through structured medical and behavioral therapies with typical lengths of stay ranging from three to twelve days.

• Specialty treatment facilities primarily consist of residential recovery facilities that provide a continuum of care for adults with addictive disorders and co-occurring mental disorders, offering detoxification, inpatient, partial hospitalization, and outpatient treatment in a supportive environment with individualized programs using modalities such as twelve-step philosophy and cognitive behavioral therapies.

• Comprehensive treatment centers specialize in medication-assisted treatment for opioid use disorders in an outpatient setting, combining behavioral therapy with medication to normalize brain chemistry and block euphoric effects of opioids, while providing services such as treatment planning, medication management, individual and group therapy, peer support, vocational training, and social support.

• Residential treatment centers treat patients with behavioral disorders in a non-hospital setting, balancing therapy with social, academic, and other activities through medically driven interventions and individualized treatment regimens for moderate to high acuity patients, including adolescents with histories of trauma, substance abuse, and psychiatric disorders, with lengths of stay ranging from three months to several years.

Acadia Healthcare Company, Inc. is a leading publicly traded pure-play provider of behavioral healthcare services in the U. S., positioned as a dominant platform in a highly fragmented industry, with competitive advantages derived from its national footprint, scale, diversified revenue and payor bases, and experienced management team with deep expertise in healthcare operations and clinical care.

The company serves patients referred by healthcare practitioners, public programs, other treatment facilities, managed care organizations, unions, emergency departments, judicial officials, social workers, police departments, and word of mouth from previously treated patients and their families, with a payor mix consisting of 57.7% Medicaid, 24.6% commercial payors, 14.3% Medicare, and 3.4% other payors for the year ended December 31, 2025.